Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue SUPPL. 5, 2014, Pages 17-26

  Rouzaud, M ^a   Sevrain, M ^b   Villani, A P ^c   Barnetche, T ^d   Paul, C ^e   Richard, M A ^f   Jullien, D ^c   Misery, L ^b   Le Maitre M ^g   Aractingi, S ^h   Aubin, F ⁱ   Joly, P ^j   Cantagrel, A ^k   Ortonne, J P ^l   Beylot Barry, M ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE LYON   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e University of Toulouse III   (France)

^f AIX MARSEILLE UNIVERSITY   (France)

^g Dermatologist   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ UNIVERSITY HOSPITAL OF BESANÇON   (France)

^j ROUEN UNIVERSITY HOSPITAL   (France)

^k CHU PURPAN   (France)

^l UNIVERSITÉ CÔTE D'AZUR   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRITIS; BODY SURFACE; CLINICAL FEATURE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; HAZARD RATIO; HUMAN; INTERPHALANGEAL JOINT; META ANALYSIS; NAIL PSORIASIS; ONYCHOLYSIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; REVIEW; SCALP; SYSTEMATIC REVIEW; AGE; ARTHRITIS, PSORIATIC; NAIL; PATHOLOGY; RISK FACTOR; SKIN;

AGE FACTORS; ARTHRITIS, PSORIATIC; HUMANS; NAILS; PHENOTYPE; RISK FACTORS; SKIN;

EID: 84903750960     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12562     Document Type: Review

References (42)

1. National Psoriasis Foundation. About Psoriasis: statistics. Available at: http://www.psoriasis.org/about/stats. (last accessed: 11 January 2010).
2. Prey S, Paul C, Bronsard V, et al,. Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature. J Eur Acad Dermatol Venereol 2010; 24 (Suppl 2): 31-35.
3. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK,. Psoriatic arthritis (PSA)-an analysis of 220 patients. Q J Med 1987; 62: 127-141.
4. Kane D, Stafford L, Bresnihan B, FitzGerald O,. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 2003; 42: 1460-1468.
5. McHugh NJ, Balachrishnan C, Jones SM,. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford) 2003; 42: 778-783.
6. Setty AR, Choi HK,. Psoriatic arthritis epidemiology. Curr Rheumatol Rep 2007; 9: 449-454.
7. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H,. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-2673.
8. Fitzgerald O, Winchester R,. Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res Ther 2009; 11: 214.
9. Richard MA, Barnetche T, Rouzaud M, et al,. Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: systematic review and expert opinion. J Eur Acad Dermatol Venereol 2014; 28 (Suppl. 5): 3-12.
10. Vandenbroucke JP, von Elm E, Altman DG, et al,. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med 2007; 8: W163-W194.
11. Wells GA, Shea B, O'Connell D, et al,. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical-epidemiology/oxford.htm (last accessed: 17 May 2013).
12. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM,. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 2009; 61: 233-239.
13. Tey HL, Ee HL, Tan AS, Theng TS, Wong SN, Khoo SW,. Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis. J Dermatol 2010; 37: 426-430.
14. Love TJ, Gudjonsson JE, Valdimarsson H, Gudbjornsson B,. Psoriatic arthritis and onycholysis-results from the cross-sectional Reykjavik psoriatic arthritis study. J Rheumatol 2012; 39: 1441-1444.
15. Gladman DD, Chandran V,. Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford) 2011; 50: 25-31.
16. Yang Q, Qu L, Tian H, et al,. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis. J Eur Acad Dermatol Venereol 2011; 25: 1409-1414.
17. Soltani-Arabshahi R, Wong B, Feng BJ, Goldgar DE, Duffin KC, Krueger GG,. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol 2010; 146: 721-726.
18. Christophers E, Barker JN, Griffiths CE, et al,. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol 2010; 24: 548-554.
19. Reich K, Krüger K, Mössner R, Augustin M,. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009; 160: 1040-1047.
20. Jamshidi F, Bouzari N, Seirafi H, Farnaghi F, Firooz A,. The prevalence of psoriatic arthritis in psoriatic patients in Tehran. Iran. Arch Iran Med 2008; 11: 162-165.
21. Salvarani C, Lo Scocco G, Macchioni P, et al,. Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol 1995; 22: 1499-1503.
22. Stern RS,. The epidemiology of joint complaints in patients with psoriasis. J Rheumatol 1985; 12: 315-320.
23. Palmou N, Marzo-Ortega H, Ash Z, et al,. Linear pitting and splinter haemorrhages are more commonly seen in the nails of patients with established psoriasis in comparison to psoriatic arthritis. Dermatology 2011; 223: 370-373.
24. Soy M, Karaca N, Umit EU, Bes C, Piskin S,. Joint and nail involvement in Turkish patients with psoriatic arthritis. Rheumatol Int 2008; 29: 223-225.
25. Zanolli MD, Wikle JS,. Joint complaints in psoriasis patients. Int J Dermatol 1992; 31: 488-491.
26. Thumboo J, Uramoto K, Shbeeb MI, et al,. Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol 2002; 29: 757-762.
27. Eder L, Law T, Chandran V, et al,. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken) 2011; 63: 1091-1097.
28. Maejima H, Taniguchi T, Watarai A, Katsuoka K,. Evaluation of nail disease in psoriatic arthritis by using a modified nail psoriasis severity score index. Int J Dermatol 2010; 49: 901-906.
29. Scarpa R, Oriente P, Pucino A, et al,. Psoriatic arthritis in psoriatic patients. Br J Rheumatol 1984; 23: 246-250.
30. Love TJ, Gudjonsson JE, Valdimarsson H, Gudbjornsson B,. Small joint involvement in psoriatic arthritis is associated with onycholysis: the Reykjavik Psoriatic Arthritis Study. Scand J Rheumatol 2010; 39: 299-302.
31. Scarpa R, Soscia E, Peluso R, et al,. Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol 2006; 33: 1315-1319.
32. Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ,. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994; 33: 834-839.
33. Cohen MR, Reda DJ, Clegg DO,. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. J Rheumatol 1999; 26: 1752-1756.
34. Moghaddassi M, Shahram F, Chams-Davatchi C, Najafizadeh SR, Davatchi F,. Different aspects of psoriasis: analysis of 150 Iranian patients. Arch Iran Med 2009; 12: 279-283.
35. Scarpa R, Manguso F, Oriente A, Peluso R, Atteno M, Oriente P,. Is the involvement of the distal interphalangeal joint in psoriatic patients related to nail psoriasis? Clin Rheumatol 2004; 23: 27-30.
36. Gelfand JM, Gladman DD, Mease PJ, et al,. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53: 573.
37. Anandarajah AP, Ritchlin CT,. Pathogenesis of psoriatic arthritis. Curr Opin Rheumatol 2004; 16: 338-343.
38. Hueber AJ, McInnes IB,. Immune regulation in psoriasis and psoriatic arthritis: recent developments. Immunol Lett 2007; 114: 59-65.
39. Gisondi P, Girolomoni G, Sampogna F, Tabolli S, Abeni D,. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. Eur J Dermatol 2005; 15: 279-283.
40. Zachariae H, Zachariae R, Blomqvist K, et al,. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol (Stockh) 2002; 82: 108-113.
41. McGonagle D, Tan AL, Benjamin M,. The nail as a musculoskeletal appendage-implications for an improved understanding of the link between psoriasis and arthritis. Dermatology 2009; 218: 97-102.
42. Tan AL, Benjamin M, Toumi H, et al,. The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis -a high-resolution MRI and histological study. Rheumatology (Oxford) 2007; 46: 253-256.